TY - JOUR
T1 - Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer
AU - Redding, Spencer W.
AU - Zellars, Richard C.
AU - Kirkpatrick, William R.
AU - McAtee, Robert K.
AU - Caceres, Marta A.
AU - Fothergill, Annette W.
AU - Lopez-Ribot, Jose L.
AU - Bailey, Cliff W.
AU - Rinaldi, Michael G.
AU - Patterson, Thomas F.
PY - 1999/12
Y1 - 1999/12
N2 - Oral mucosal colonization and infection with Candida are common in patients receiving radiation therapy for head and neck cancer. Infection is marked by oral pain and/or burning and can lead to significant patient morbidity. The purpose of this study was to identify Candida strain diversity in this population by using a chromogenic medium, subculturing, molecular typing, and antifungal susceptibility testing of clinical isolates. These results were then correlated with clinical outcome in patients treated with fluconazole for infection. Specimens from 30 patients receiving radiation therapy for head and neck cancer were cultured weekly for Candida. Patients exhibiting clinical infection were treated with oral fluconazole. All isolates were plated on CHROMagar Candida and RPMI medium, subcultured, and submitted for antifungal susceptibility testing and molecular typing. Infections occurred in 27% of the patients and were predominantly due to Candida albicans (78%). Candida carriage occurred in 73% of patients and at 51% of patient visits. Yeasts other than C. albicans predominated in carriage, as they were isolated from 59% of patients and at 52% of patient visits. All infections responded clinically, and all isolates were susceptible to fluconazole. Molecular typing showed that most patients had similar strains throughout their radiation treatment. One patient, however, did show the acquisition of a new strain. With this high rate of infection (27%), prophylaxis to prevent infection should be evaluated for these patients.
AB - Oral mucosal colonization and infection with Candida are common in patients receiving radiation therapy for head and neck cancer. Infection is marked by oral pain and/or burning and can lead to significant patient morbidity. The purpose of this study was to identify Candida strain diversity in this population by using a chromogenic medium, subculturing, molecular typing, and antifungal susceptibility testing of clinical isolates. These results were then correlated with clinical outcome in patients treated with fluconazole for infection. Specimens from 30 patients receiving radiation therapy for head and neck cancer were cultured weekly for Candida. Patients exhibiting clinical infection were treated with oral fluconazole. All isolates were plated on CHROMagar Candida and RPMI medium, subcultured, and submitted for antifungal susceptibility testing and molecular typing. Infections occurred in 27% of the patients and were predominantly due to Candida albicans (78%). Candida carriage occurred in 73% of patients and at 51% of patient visits. Yeasts other than C. albicans predominated in carriage, as they were isolated from 59% of patients and at 52% of patient visits. All infections responded clinically, and all isolates were susceptible to fluconazole. Molecular typing showed that most patients had similar strains throughout their radiation treatment. One patient, however, did show the acquisition of a new strain. With this high rate of infection (27%), prophylaxis to prevent infection should be evaluated for these patients.
UR - http://www.scopus.com/inward/record.url?scp=0032723144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032723144&partnerID=8YFLogxK
U2 - 10.1128/jcm.37.12.3896-3900.1999
DO - 10.1128/jcm.37.12.3896-3900.1999
M3 - Article
C2 - 10565903
AN - SCOPUS:0032723144
SN - 0095-1137
VL - 37
SP - 3896
EP - 3900
JO - Journal of clinical microbiology
JF - Journal of clinical microbiology
IS - 12
ER -